Prof Javier Escaned (Hospital Clinico San Carlos, Madrid, ES) discusses the long term effect of bioresorbable scaffolds and metallic drug eluting stents (DES) on human coronary hemodynamics, following the results from the latest ABSORB II randomised trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology
1. Why did you conduct this research?
2. Which devices were followed and how was the data collected and analysed?
3. What were your findings?
4. Does BRS technology have a future?
Videographer: Tom Green
Education Lead: Liam O'Neill